Tickers

METC — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-22 10:21:15.628076 UTC · finished 2026-09-22 10:24:53.729484 UTC

1. Composite Trajectory Verdict

Given METC's business model as a metallurgical coal producer with a pre-revenue rare earths development project, all three statements carry weight: the income statement reflects commodity-driven earnings volatility and rising development costs, the cash flow statement shows whether operations fund the business or require external financing, and the balance sheet tracks the liquidity cushion and leverage from recent large debt/equity raises.

Composite Trajectory: Deteriorating

The income statement shows a clear deterioration: full-year 2025 revenue fell 19% to $536.6M from $666.3M in 2024, operating income swung from a $16.6M gain to a $56.0M loss, and net income fell from an $11.2M profit to a $51.4M loss (10-K 2025, Consolidated Statements of Operations). The first half of 2026 continued the trend with revenue down 7.4% year-over-year to $266.4M and the six-month net loss widening to $33.7M from $23.4M (10-Q 2026-06-30, Condensed Statements of Operations). Cash generation deteriorated sharply: annual operating cash flow collapsed to $2.0M in 2025 from $112.7M in 2024, and the first six months of 2026 used $22.4M in operating activities (10-K 2025, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, MD&A Liquidity). The balance sheet shows high absolute liquidity ($282.5M cash plus $117.6M revolver availability at June 30, 2026) but cash has fallen $157.8M in six months while long-term debt remains elevated at $452.8M net, and equity declined $107.5M due to losses and $65.9M of share repurchases (10-Q 2026-06-30, Condensed Balance Sheets; MD&A Liquidity).

2. Red Flags

  • Operating cash flow collapsed 98% year-over-year to $2.0M in 2025 from $112.7M in 2024, and turned negative (-$22.4M) in the first half of 2026 (10-K 2025, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, MD&A Liquidity).
  • Net losses have widened across three consecutive annual periods: $82.3M profit (2023) → $11.2M profit (2024) → $51.4M loss (2025), with the first half of 2026 showing a $33.7M loss vs $23.4M loss in H1 2025 (10-K 2025, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Statements of Operations).
  • SG&A expenses rose 41% to $69.4M in 2025 (driven by $9.1M professional services, $5.2M labor, $7.1M rare earth development costs) and rose a further 27% year-over-year in H1 2026 to $37.9M (10-K 2025, MD&A; 10-Q 2026-06-30, MD&A).
  • Inventory doubled to $87.2M at December 31, 2025 from $43.4M a year earlier, and rose another 15% to $100.4M at June 30, 2026, while revenue declined (10-K 2025, Balance Sheet; 10-Q 2026-06-30, Condensed Balance Sheets).
  • The company issued $410M of new debt (2030 Senior Notes $65M + 2031 Convertible Notes $345M) and $189M of equity in 2025, yet repurchased $65.9M of stock in H1 2026 while generating operating losses and negative operating cash flow (10-K 2025, MD&A Indebtedness and Cash Flows; 10-Q 2026-06-30, MD&A Liquidity).
  • A class action lawsuit was filed January 30, 2026 alleging materially false statements about the Brook Mine development during July–October 2025 (10-K 2025, Note 9 Litigation).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Revenue has declined for two consecutive full years, falling 19% to $536.6M in 2025 from $666.3M in 2024 (which was already down 4% from $693.5M in 2023), driven by lower metallurgical coal pricing and modest volume reductions (10-K 2025, Consolidated Statements of Operations). The first six months of 2026 continued the decline with revenue down 7.4% year-over-year to $266.4M (10-Q 2026-06-30, Condensed Statements of Operations). Operating results swung from a $95.2M profit in 2023 to a $16.6M profit in 2024 to a $56.0M loss in 2025, with the H1 2026 operating loss widening to $42.6M from $25.9M in H1 2025 (10-K 2025, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Statements of Operations). Net income followed the same pattern: $82.3M → $11.2M → -$51.4M annually, and -$33.7M vs -$23.4M for the comparable six-month periods (same sources). The Rare Earths segment recorded no revenue in any period and its Segment Adjusted EBITDA loss widened from -$6.3M in 2024 to -$18.3M in 2025 and to -$12.0M in H1 2026 from -$8.5M in H1 2025 (10-K 2025, Segment Reporting; 10-Q 2026-06-30, Segment Results).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Annual operating cash flow fell from $161.0M (2023) to $112.7M (2024) to $2.0M (2025), a 98% year-over-year drop in 2025 attributed to lower cash earnings and a $39.4M unfavorable swing in working capital driven by inventory increases (10-K 2025, Consolidated Statements of Cash Flows and MD&A). The first six months of 2026 used $22.4M in operating activities, reflecting the net loss adjusted for non-cash items and increases in receivables and inventory (10-Q 2026-06-30, MD&A Liquidity). Capital expenditures remained substantial at $62.8M in 2025 and $44.6M in H1 2026 (including grant offsets), resulting in negative free cash flow in both periods (10-K 2025, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, MD&A Liquidity). Financing cash flows flipped from -$50.8M in 2024 to +$489.0M in 2025 due to debt and equity issuance, but turned negative -$91.0M in H1 2026 primarily from $65.9M of share repurchases and $17.6M of tax withholding payments (10-K 2025, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, MD&A Liquidity).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Liquidity remains high in absolute terms: $282.5M cash plus $117.6M revolver availability at June 30, 2026, with current assets exceeding current liabilities by $351.8M (10-Q 2026-06-30, Condensed Balance Sheets and MD&A). However, cash has declined $157.8M from the December 31, 2025 peak of $440.3M, which itself was funded by the late-2025 financing surge (10-K 2025, Balance Sheet; 10-Q 2026-06-30, Condensed Balance Sheets). Net long-term debt stands at $452.8M, up from $88.2M at end-2024, comprising $65M 2030 Notes, $57.5M 2029 Notes, and $345M 2031 Convertible Notes (10-K 2025, Note 6; 10-Q 2026-06-30, Condensed Balance Sheets). Stockholders' equity fell $107.5M in six months to $376.1M due to the $33.7M net loss and $65.9M of treasury stock purchases (10-Q 2026-06-30, Condensed Balance Sheets and Consolidated Statements of Equity). Inventory rose to $100.4M from $43.4M a year earlier while accounts receivable increased to $60.7M from $54.4M over the same six-month window, indicating working capital absorption (10-K 2025, Balance Sheet; 10-Q 2026-06-30, Condensed Balance Sheets).

6. Data Gaps

  • Quarterly cash flow statements for Q1 2026, Q4 2025, Q3 2025, and Q2 2025 (only annual 2025 and H1 2026 MD&A commentary provided).
  • Full 10-Q financial statements for periods 2026-03-31, 2025-09-30, and 2025-06-30 (listed as provided but not included in the filing content).
  • Segment-level capital expenditure breakdown for quarterly periods (only annual segment capex disclosed in 10-K Note 14).
  • Updated contractual obligations table as of June 30, 2026 (10-Q states "no material changes" from 10-K but does not reproduce the table).
  • GAAP revenue and cost per ton for standalone Q2 2026 (only three-month and six-month aggregates provided in 10-Q).
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status